Aclaris Therapeutics, INC. DEFA14A Filing

Ticker: ACRS · Form: DEFA14A · Filed: Apr 23, 2026 · CIK: 0001557746

Aclaris Therapeutics, INC. DEFA14A Filing Summary
FieldDetail
CompanyAclaris Therapeutics, INC. (ACRS)
Form TypeDEFA14A
Filed DateApr 23, 2026
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a DEFA14A filing submitted by Aclaris Therapeutics, INC. (ticker: ACRS) to the SEC on Apr 23, 2026.

Where can I view the full DEFA14A filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 23, 2026 regarding Aclaris Therapeutics, Inc. (ACRS).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing